Catalyst Funds Management Pty LTD Caribou Biosciences, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 7,800 shares of CRBU stock, worth $17,160. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,800Holding current value
$17,160% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
142Shares Held
52.1MCall Options Held
37.4KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$15.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$10.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.57MShares$10.1 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.31MShares$9.47 Million0.49% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.36MShares$5.18 Million0.38% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $134M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...